AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
ECNO Glutide: A New Drug That Underwent a New Study
ECNO Glutide is the latest drug to undergo a phase two study. It's kind of like creatine in a way you just take it whenever, as long as you remember to take it, it will, it'll work. I feel like with these medicines of like, we have like a thousand different ways to hit this receptor and they all cause weight loss. And so that's a matter of accessibility and cost and things like that.